Cargando…
Prognostic relevance of protein expression, clinical factors, and MYD88 mutation in primary bone lymphoma
Primary bone lymphomas (PBLs) are composed of malignant lymphoid cells presenting in osseous sites, without supra-regional lymph node or extranodal involvement. We systematically characterized the immunophenotype and the myeloid differentiation factor 88 (MYD88)-L265P gene mutation status in PBL. Cl...
Autores principales: | Xu, Yong, Li, Jian, Ouyang, Jian, Li, Juan, Xu, Jingyan, Zhang, Qiguo, Yang, Yonggong, Zhou, Min, Wang, Jing, Zhang, Cuiling, Xu, Yueyi, Li, Ping, Zhou, Rongfu, Chen, Bing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5630357/ https://www.ncbi.nlm.nih.gov/pubmed/29029457 http://dx.doi.org/10.18632/oncotarget.19936 |
Ejemplares similares
-
MYD88(L265P) and MYD88(other) variants show different molecular characteristics and prognostic significance in diffuse large B-cell lymphoma
por: Qin, Yan, et al.
Publicado: (2023) -
SYK is activated by mutated MYD88 and drives pro-survival signaling in MYD88 driven B-cell lymphomas
por: Munshi, Manit, et al.
Publicado: (2020) -
High-Dose Chemotherapy Followed by Autologous Stem Cell Transplantation as a First-Line Therapy for High-Risk Primary Breast Cancer: A Meta-Analysis
por: Wang, Jing, et al.
Publicado: (2012) -
Correction: High-Dose Chemotherapy Followed by Autologous Stem Cell Transplantation as a First-Line Therapy for High-Risk Primary Breast Cancer: A Meta-Analysis
por: Wang, Jing, et al.
Publicado: (2012) -
Identification and Function of Myeloid Differentiation Factor 88 (MyD88) in Litopenaeus vannamei
por: Zhang, Shuang, et al.
Publicado: (2012)